The Deposit Return Scheme garnered a post-tax surplus of almost €80 million since 2024.
Asked whether this money could be put towards the Skyclarys drug to help fatal Friedreich’s Ataxia sufferers, Tánaiste Simon Harris replied “The short answer is no.”